This HTML5 document contains 142 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n10http://dx.doi.org/10.2147/

Statements

Subject Item
wd:Q37151347
rdf:type
wikibase:Item
schema:description
مقالة علمية نشرت في 25 يوليو 2013 vedecký článok vědecký článek artículu científicu espublizáu en 2013 articolo scientifico article científic vetenskaplig artikel wissenschaftlicher Artikel bilimsel makale научни чланак scientific article published on 25 July 2013 videnskabelig artikel article scientifique наукова стаття, опублікована в липні 2013 artigo científico wetenschappelijk artikel
p:P577
wds:Q37151347-88130E18-1D48-4D36-AB4E-FDC687E47A0D
wdt:P577
2013-07-25T00:00:00Z
p:P407
wds:Q37151347-6B5253D9-77EB-4C79-BD67-30F191FE2267
wdt:P407
wd:Q1860
p:P2860
wds:Q37151347-2DDB30B6-D9F2-413D-81CD-162E33B9F238 wds:Q37151347-2FA52946-202B-4E2D-A0B7-B7CE804335E1 wds:Q37151347-1ED3706C-BFA3-433A-8F76-9ACF0EFCD829 wds:Q37151347-21B44962-2A82-46FA-8013-25D0951C4BA2 wds:Q37151347-23943B68-E128-43C7-95B7-DF62B31F7C90 wds:Q37151347-49CDFC95-7459-4C6E-A0F6-217D45B643A4 wds:Q37151347-53D69445-583D-40E7-8F61-65CA72139CA1 wds:Q37151347-3D366E0A-9129-4D7A-AB42-79E8B73BC0AF wds:Q37151347-3DEA3C14-784D-4EED-96C5-81550991430B wds:Q37151347-41547A45-52A4-400B-96D2-4BBFAB52A145 wds:Q37151347-4264AC11-404E-4D1A-9225-EB3DCDC960F8 wds:Q37151347-83CB8616-5911-4FAC-BF5F-FA9D1FB46DF9 wds:Q37151347-872D5577-6DA7-410B-9D0D-81C70D36F968 wds:Q37151347-0C6902F6-CD8A-44A5-AA87-F4075B01859B wds:Q37151347-7D85F4CC-62C5-4433-AD10-9A5F67DDF83B wds:Q37151347-8013E3A7-868D-47A5-B677-1EA7681DF7F5 wds:Q37151347-817CA029-CC70-4F1F-81DD-8B92E09027E0 wds:Q37151347-82E775A4-5F1A-4C61-9BD8-864C9FD46E37 wds:Q37151347-D09EE232-DAAD-437E-A2EF-B9E7EDE80DFC wds:Q37151347-D19470E2-12DD-4998-91D9-71594A2C836A wds:Q37151347-B5F1388C-391A-4718-A490-ABAFC083538B wds:Q37151347-BF16B991-FDDC-4D8A-BFC0-01ABF9F4493F wds:Q37151347-CA7AF2C1-5B44-42C2-BB5D-259273F724D5 wds:Q37151347-D04C19A9-AAF2-43E1-990F-CAEAC0824C41 wds:Q37151347-64FCF691-EEF7-4BAF-A852-426B3F9368E6 wds:Q37151347-66D75083-3635-4C43-B1FB-B17DEC9B300A wds:Q37151347-5C2D437C-959C-4D5D-B1A8-657F8665C83B wds:Q37151347-5DD1E84B-CAD1-4E64-B6B6-AFE41FFEA4A5 wds:Q37151347-5FCEDCD5-04E6-4877-8FB9-18ABD3D1314A wds:Q37151347-78ED8C8A-2F20-48C8-8A61-3C8FFFBD2E2B wds:Q37151347-798CD93A-926C-42F0-ABD9-326C57CB9DB1 wds:Q37151347-7CCB1D62-0D87-4B26-89C3-C82E050247EA wds:Q37151347-6F7F1BB2-2063-4ADF-B434-939C6AF91CEB wds:Q37151347-771D4BC6-A8C3-4D08-A123-594937326187 wds:Q37151347-EFFC0B4F-9825-4BFE-B812-29E59E8A455C wds:Q37151347-F4619828-3DF7-4128-84C9-6900AA24B851 wds:Q37151347-F90E8342-5444-43E9-A685-93CEAB3A7387 wds:Q37151347-DC37C2F8-52DA-4505-A952-5BEF2FA49CE2
wdt:P2860
wd:Q46602475 wd:Q36955489 wd:Q29619886 wd:Q44705149 wd:Q45256257 wd:Q51681449 wd:Q46309781 wd:Q68127291 wd:Q34686089 wd:Q51590843 wd:Q46627323 wd:Q34686103 wd:Q38456774 wd:Q53983782 wd:Q51496275 wd:Q34985342 wd:Q51494224 wd:Q38003533 wd:Q74366194 wd:Q43756358 wd:Q35906026 wd:Q30490289 wd:Q54274801 wd:Q29618673 wd:Q34766176 wd:Q51657700 wd:Q80519509 wd:Q38012205 wd:Q75205685 wd:Q53857409 wd:Q46600190 wd:Q46570674 wd:Q79615264 wd:Q40102509 wd:Q22250883 wd:Q80655766 wd:Q41556880 wd:Q41840439
p:P2093
wds:Q37151347-E788F27F-5A1A-4F7C-9157-094549D6BA93 wds:Q37151347-76EDFC9D-0529-4BE5-AD66-8F56599FB1A0
wdt:P2093
Honglin Hu Cong Zou
rdfs:label
Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk. Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk
skos:prefLabel
Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk. Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk
schema:name
Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk.
p:P1476
wds:Q37151347-A39EC7AC-17A4-4898-8312-08CC546A7EF9
wdt:P1476
Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk
p:P304
wds:Q37151347-3CF02F9E-8FF1-40FD-AEBA-8B933D4E8CFB
wdt:P304
429-433
p:P31
wds:Q37151347-5FD60156-3148-4D83-AE25-8F3B2FD826E5 wds:Q37151347-08DAF705-19DB-4376-A66D-63F5BB8171DB
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q37151347-7957502B-6C54-4857-B919-869A2910752F wds:Q37151347-6AA756E7-7A33-475F-A20F-7F13D5BD3D8D wds:Q37151347-53BC8D5E-0563-411F-B9F2-342D1ABD9BFA wds:Q37151347-E8B20741-384A-4518-8621-E1E05A9EB020
wdt:P921
wd:Q2420555 wd:Q3025883 wd:Q389735 wd:Q575062
p:P698
wds:Q37151347-3580BA5D-7DE6-44EA-B726-F5607302F90E
wdtn:P698
n6:24023518
wdt:P698
24023518
p:P1433
wds:Q37151347-D7765BC7-8920-4FF4-8C87-46C78F46FA14
wdt:P1433
wd:Q7916443
p:P478
wds:Q37151347-E25DFB9D-6E5F-4DEA-9F67-A4D88C711D8C
wdt:P478
9
p:P356
wds:Q37151347-12FD1CA6-CBDB-4518-AE9D-A645002B8ACC
wdtn:P356
n10:VHRM.S34421
wdt:P356
10.2147/VHRM.S34421
p:P275
wds:Q37151347-78DE6E5A-4085-466D-BBC9-CBBBE5D69FBA
p:P5008
wds:Q37151347-D53E080F-9D24-4011-AC39-B3B714C3E5EF
wdt:P275
wd:Q6936496
wdt:P5008
wd:Q55439927
p:P932
wds:Q37151347-473AAB31-3217-4325-A7CD-0F52CD920665
wdt:P932
3764952